procurement of hospital medicine - 1. n-butyl cyanoacrylate 0.5ml inj 2. tirzepatide 15 mg inj multidose pfp 3. romosozumab inj 105 mg per 1.17 ml 4. 17 gauge breast tissue marker ,coil/ribbon shape , colour coded trigger for different shapes, visible in usg, mamo, mri usfda (bbqr att below) 5. haemostatic clips titanium haemostatic clips medium lt 200 with applicator (bbqr att below) 6. primidone 25 mg tab 7. triclofos syp, 500mg/5ml in 30ml bottle 8. inj obinutuzumab 1000 mg/40ml 9. bcr-abl-q

Ministry Of Defence has invited bids for the procurement of hospital medicine - 1. n-butyl cyanoacrylate 0.5ml inj 2. tirzepatide 15 mg inj multidose pfp 3. romosozumab inj 105 mg per 1.17 ml 4. 17 gauge breast tissue marker ,coil/ribbon shape , colour coded trigger for different shapes, visible in usg, mamo, mri usfda (bbqr att below) 5. haemostatic clips titanium haemostatic clips medium lt 200 with applicator (bbqr att below) 6. primidone 25 mg tab 7. triclofos syp, 500mg/5ml in 30ml bottle 8. inj obinutuzumab 1000 mg/40ml 9. bcr-abl-quantitative kit for major,minor&micro transcripts and calibrator for who is reporting of major .transcript.(kit of 48 tests) 10. fibrinogen human, bottle of 1gm. The estimated project cost is ₹0.03 Cr. Please refer to the tender document for EMD details. Interested bidders can submit applications until 22 September 2026, with the technical opening scheduled for 22 September 2026.